News

June 20, 2019June 20, 2019

Snail Slime May Lead to New CF Treatments Because of Its Antimicrobial Proteins

cystic fibrosis, News

Small proteins with antimicrobial properties found in the mucus of the brown garden snail may open the door to the development of new treatments for patients with cystic fibrosis ... Read more

June 19, 2019June 19, 2019

UK’s Cystic Fibrosis Trust Urges Participation in ‘Wear Yellow Day’ June 21

cystic fibrosis, News

If the Cystic Fibrosis Trust (CFT) has its way, the United Kingdom will be awash in yellow on June 21. On that day, the nonprofit organization is asking patients and ... Read more

June 18, 2019June 18, 2019

Kalydeco Shows Long-term Efficacy in CF Patients in Real-world Setting

cystic fibrosis, News

Kalydeco (ivacaftor) preserved lung function, improved the nutritional status, and reduced hospital visits and chronic bacterial infections in people with cystic fibrosis (CF) when administered for up to five years ... Read more

June 17, 2019June 17, 2019

Eluforsen Found to be Safe for Adults with Cystic Fibrosis Caused by F508del Mutation, Study Reports

cystic fibrosis, News

The experimental treatment eluforsen is safe for adults with cystic fibrosis (CF) caused by a mutation called F508del, a new study reports, supporting further investigation and development of the ... Read more

June 15, 2019June 6, 2019

31 Days of CF: Maddie’s Story

31 days of CF, News

View this post on Instagram Day 16 of 31 Days of CF ⁣⁣ Topic: Balancing work, grad school, and health⁣⁣ ⁣⁣ Here are @saltymaddie93 experiences: ⁣⁣ ⁣⁣ In fall ... Read more

June 14, 2019June 14, 2019

Bronchitol, Inhalation Powder for CF Patients, to Enter Swiss Market

cystic fibrosis, News

EffRx Pharmaceuticals announced that it has signed an exclusive license agreement with Pharmaxis to register and commercialize Bronchitol (mannitol) for the treatment of cystic fibrosis (CF) in Switzerland. According to ... Read more

June 13, 2019June 13, 2019

Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical Data Show

cystic fibrosis, News

Murepavadin (POL7080), Polyphor‘s lead investigational antibiotic targeting Gram-negative bacteria, behaved as expected and was well-tolerated when administered to mice harboring a lung infection caused by Pseudomonas aeruginosa, data from ... Read more

June 12, 2019June 12, 2019

Inhaled Imipenem/cilastatin an Alternative Treatment for Lung Infection in Children with CF, Case Reports Show

cystic fibrosis, News

The inhaled formulation of broad-spectrum antibiotics such as imipenem/cilastatin is a useful alternative to treat chronic lung bacterial infections in children with cystic fibrosis (CF) because it causes fewer side ... Read more

June 11, 2019June 11, 2019

Kalydeco Restored Pancreatic Function in Boy with CF, Case Report Suggests

cystic fibrosis, News

A case report about a 10-year-old boy suggests that Vertex Pharmaceuticals‘ Kalydeco (ivacaftor) can restore the function of the pancreas and the production of pancreatic enzymes in children with ... Read more

June 10, 2019June 10, 2019

Candidate Therapy ELX-02 Shows Positive Results in Preclinical and Phase 1 Studies

News

Data from Phase 1 studies in healthy people and preclinical work indicate that ELX-02 may help to treat cystic fibrosis (CF), Eloxx Pharmaceuticals, its developer, reported. The therapy was well-tolerated in ... Read more

Pin It on Pinterest